Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. The company offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. It also provides specialty chemicals, such as acetonitrile; 1,8-diazabicyclo[5.4.0]undec-7-ene; diethylketone/3-pentanone; alchan 100; alchan 300; 2-aminoethoxy ethanol; 2-ethoxy ethylamine; dimethylpropyleneurea; tetramethyl ethylenediamine; monomethylamine; and tempo, free radical. The company serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. Alkyl Amines Chemicals Limited was incorporated in 1979 and is headquartered in Navi Mumbai, India.

Revenue projections:

Revenue projections for ALKYLAMINE
Revenue projections for ALKYLAMINE

With ALKYLAMINE's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio 0.00000
forwardPE 33.20093
debtToEquity 0.39400
earningsGrowth 0.01000
revenueGrowth 0.01500
grossMargins 0.45111
operatingMargins 0.14470
trailingEps 36.45000
forwardEps 0.00000

ALKYLAMINE's negative gross and operating margins suggest that the company is experiencing losses at both the production and operational levels. This could point to inefficiencies or declining demand for its products.

Price projections:

Price projections for ALKYLAMINE
Price projections for ALKYLAMINE

The current valuation of ALKYLAMINE against its projections does not reveal significant risks or opportunities. This neutral assessment implies a stable market, where investors may prefer to maintain their positions until future trends become clearer.

Insider Transactions:

Insider Transactions for ALKYLAMINE
Insider Transactions for ALKYLAMINE


16 transactions to sell ALKYLAMINE occurred, with market price at 2057.6843643188477.ALKYLAMINE had 10 buy transactions while market price was at 1784.875 per share.ALKYLAMINE's current price levels are experiencing more selling than buying, which may suggest further declines. If the trend persists, it could lead to a continued downward trajectory as investors lose confidence in the stock's future performance.

Recommendation changes over time:

Recommendations trend for ALKYLAMINE
Recommendations trend for ALKYLAMINE


With analysts leaning toward a sell bias for ALKYLAMINE, investors should be cautious and make decisions based on a wider set of market indicators. This approach will help balance short-term concerns with longer-term market trends, providing a more holistic view of the stock.